Skip to content

National Cancer Center Hospital (NCCH) Phase1 Liquid Study

National Cancer Center Hospital (NCCH) Phase1 Liquid Study - NCCH Phase1 Liquid Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047567
Enrollment
160
Registered
2022-04-22
Start date
2021-01-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Sponsors

National Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient who pathologically diagnosed of cancer. Patient who enrolled or will enroll in an early phase clinical trial. Patient who has tissue sampling

Exclusion criteria

Exclusion criteria: No definition

Design outcomes

Primary

MeasureTime frame
Analysis of tumor and non-tumor tissue obtained based on the standardized operation procedure

Countries

Japan

Contacts

Public ContactTakafumi Koyama

National Cancer Center Hospital Department of Experimental Therapeutics

takoyama@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026